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All 4 samples were pooled on the same flow-cell lane and were 
sequenced on an Illumina HiSeq 2000.  
The data shows strong different capture affinity (and thus a difference 
in the number of reads) between cryo and FFPE samples, but roughly 
the same proportion of aligned reads. 
 
The mean target on coverage drops in the FFPE samples, as is 
expected, considering the number of sequenced reads for these 
libraries. 
 
CNA calling with the cryopreserved exome data yields 
good results, which were compared with CGH data for 
validation. 
All CNA regions which were previously detected with CGH 
analysis were correctly detected with the exome data. 
SNP calling was performed on all samples, more than 90% of the SNPs found in FFPE 
exomes were also found in the corresponding cryo exomes. 
A lower target coverage in FFPE yields a lower number of detected SNPs, for both 
samples, but FFPE-related degradations do not seem to cause false positives, in 
either samples. 
BRCA2 mutations were correctly detected in the FFPE exome data. 
All samples show the same substitution rates, thus the FFPE-related degradation is 
either completely random or its non-randomness is corrected by the mapping algorithms. 
CNA calling with the FFPE sample exome data yields 
noisy results (which may be caused by the use of frozen 
sample data as reference), but still allows for the detection of 
the Her2+ amplification. 
 
Genomic DNA has been extracted from both cryopreserved and formalin-fixed paraffin-
embedded forms of 2 different tumor samples (triple negative, and Her2+). 
Exome sequencing has been performed  on all 4 forms, as well as SNP and CNA 
detection. A comparison of the various metrics and results related to the sequencing, 
mapping, and variants detection has been done, outlining what can, and can’t be done with 





Exome sequencing  





Future work: we’ve conjectured that the 
poor performance in CNA detection with 
FFPE data was caused by a low read depth 
correlation between the FFPE samples and 
the references used. 
 
We plan on testing the use of a pool of 
several FFPE samples as future reference to 
assess as to whether this method of CNA 
detection is also suited for FFPE data. 
 
Moreover, we plan on increasing the read 
coverage of future FFPE exome libraries to 
allow for better comparisons with cryo 
libraries. 
SAMPLE TN Cryo Her2+ Cryo TN FFPE Her2+ FFPE 
GENOME_SIZE  3 101 804 741  3 101 804 741  3 101 804 741  3 101 804 741 
TARGET_TERRITORY   62 286 318   62 286 318   62 286 318   62 286 318 
TOTAL_READS   76 963 934   70 975 202   37 298 532   22 505 872 
PF_UNIQUE_READS   72 257 335   66 407 261   34 041 479   21 028 247 
PCT_PF_UQ_READS 93.88% 93.56% 91.27% 93.43% 
MEAN_TARGET_COVERAGE     49.30     45.12     25.31     14.20 
PCT_PF_UQ_READS_ALIGNED 87.97% 88.38% 90.13% 87.16% 
ZERO_CVG_TARGETS_PCT 0.57% 0.73% 2.31% 3.53% 
